MedWatch

Orphazyme creditors approve restructuring plan

Creditors of embattled biotech company Orphazyme have approved its restructuring plan, the firm announces.

Photo: Nikolaj Skydsgaard/Reuters/Ritzau Scanpix

Last month, Orphazyme started a restructuring process, and creditors have now approved the rescue plan released last week.

This was revealed on Thursday after a meeting involving Orphazyme and its creditors.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs